Butorphanol (Tartrate) Overview Categories 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics2.2 Opioid analgesics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Butorphanol (Tartrate) Manufacturers of Butorphanol (Tartrate) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Butorphanol (Tartrate)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 1 to 4 mg2.5 (2.5)4 hourlyIM1 mg/spray/nostril1 (1)As recommended.Intra Nasal Spray60-90 minutes if necessory.An initial dose of 2 mg may be given in severe pain but should not be repeated 3-9 hours.0 to 2 mg/spray/nostril1 (1)4 hourlyIntra Nasal SprayIn severe pain0.5 to 2 mg1.2 (1.25)4 hourlyIV Paedriatic Dosage (20kg) Not Recommended in this Age Group Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Butorphanol (Tartrate) Back to top Manufacturers of Butorphanol (Tartrate) in Pakistan GSK Siza Back to top Previous Drug Generic - Next Drug Generic